Oscity Labs Information

Oscity BioSciences pioneers innovative, natural processes that unlock the full therapeutic potential of the human endocannabinoid system through hemp-derived, cannabinoid-based products. We manufacture our patented co-crystal technology, pharmaceutical-grade cannabinoid APIs, and compliant hemp-derived raw materials in our cGMP certified facility in Foley, Alabama. At Oscity BioSciences, our mission is to accelerate cannabinoid drug development by producing high-purity co-crystals through our proprietary patented extraction process and licensing our exclusive pioneering co-crystal IP for medication research and development—delivering superior stability, solubility, consistency, and bioavailability for research and pharmaceutical innovation in pain, epilepsy, inflammation, sleep, autoimmune and neuromuscular conditions, mood disorders, and neuroprotection. Oscity holds two granted U.S. patents, US 11,168,047 and US 11,993,563. They are the only patents covering co-crystal solid forms of THC in existence. Beyond THC, the portfolio extends across the cannabinoid spectrum — CBN, CBG, CBDV and others — making Oscity the only holder of co-crystal solid-form patents across this range of cannabinoids as a whole. No chromatography. The result is a characterized crystalline solid with one defined XRPD fingerprint, one dissolution profile, and one absorption mechanism — the same standard of molecular control pharmaceutical drugs are built on. Oscity was built from the ground up utilizing, and developing internally in some cases, the latest in technological developments and equipment. Oscity is Alabama’s largest science and technology-based biopharmaceutical manufacturing company specializing in all aspects of industrial hemp.